Ventyx Biosciences
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $1,448 | $0 |
Gross Profit | -323 | -356 | 724 | -309 |
EBITDA | -29,333 | -29,741 | -18,775 | -38,243 |
EBIT | -29,656 | -30,097 | -19,090 | -38,552 |
Net Income | -26,987 | -27,440 | -29,351 | -35,249 |
Net Change In Cash | 0 | 0 | 1,448 | 0 |
Free Cash Flow | -21,319 | -25,734 | -23,255 | -35,461 |
Cash | 32,301 | 28,076 | 27,260 | 61,765 |
Basic Shares | 71,198 | 71,131 | 70,810 | 70,667 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1,348 | -941 | -470 | -30 |
EBITDA | -133,774 | -207,836 | -107,956 | -67,117 |
EBIT | -135,122 | -207,994 | -108,426 | -67,147 |
Net Income | -135,122 | -192,962 | -107,956 | -83,746 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -5,930 | 70,547 | ||
Free Cash Flow | -131,114 | -167,036 | -99,046 | -38,912 |
Cash | 27,260 | 51,579 | 64,819 | 70,791 |
Basic Shares | 68,478 | 58,542 | 52,471 | 50,408 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.38 |
2025-03-31 | -$0.39 |
2024-12-31 | -$0.41 |
